Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Cas No. | 1096708-71-2 |
---|---|
Purity | ≥98% |
Formula | C17H12Cl2F3N7O2S |
Formula Wt. | 506.30 |
IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
http://clinicaltrials.gov/show/NCT01425008
Enone.
VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.
Glycosaminoglycan
NSAID; COX-1/2 inhibitor.
Phenylpyrazoleanilide; IL-17 production inhibit...
Cholesterol ester transfer protein inhibitor.
Endogenous pteridine metabolite of GTP.
Amino acid precursor of dopamine.
MET and GSK-3α/β inhibitor.
Macrolide; protein synthesis inhibitor. ≥3900...
HDAC inhibitor, RNA splicing inhibitor.
Synthetic peptide, stimulates gastric acid secr...
Alkaloid originally found in species of Aconitu...
Synthetic peptice; μOR agonist.
RXR agonist.
ALK inhibitor.
5-HT2 antagonist, SERT and NET inhibitor, hERG ...
Flavanol originally found in Camilla (green tea...
An omega-3 fatty acid.
Pyridopyrimidinone; PI3K and mTOR inhibitor.